Ann: ResApp Provides Australian Adult Study Enrolment Update-RAP.AX, page-2

ResApp Provides Australian Adult Study Enrolment Update Perth, Western Australia, 7 June 2016 -- ResApp Health Limited (ASX: RAP), the developer of smartphone medical applications for the diagnosis and management of respiratory disease, today announced that it has enrolled 322 adult patients (236 confirmed respiratory disease cases and 86 control cases) in its first adult study at Joondalup Health Campus. Enrolment at the Wesley Emergency Centre in Brisbane, Australia has recently started which will significantly increase the rate of enrolment and greatly expand the range of respiratory illnesses captured.

Good or Bad?